Support our Foundation of Myology project
1655 news items
A new pathogenic mechanism identified in oculo-pharyngo-distal myopathy
On 13/05/2026
Oculo-pharyngo-distal myopathy, with or without leukoencephalopathy, is caused in particular by the repetition of the GGC triplet in regions of DNA previously considered non-coding within…
Promoting the dissemination of knowledge about muscles and muscle diseases and raising the awareness of myology
On 12/05/2026
With just one month to go until the 2026 session of the AcadeMYO Summer School, we take a look back at the educational activities in…
Bioequivalence between Spinraza and its generic version, GNR-100, has been demonstrated in SMA
On 12/05/2026
GNR-100 could be the first generic version of Spinraza for SMN1-related proximal spinal muscular atrophy. A Russian study has demonstrated bioequivalence between the two products,…
Sexual dysfunction remains understudied in neuromuscular disorders
On 11/05/2026
A team from the Institute of Myology conducted a literature review to assess the current state of knowledge regarding sexual dysfunction in neuromuscular diseases. The…
Two easy-to-use tools for assessing bulbar function in SMA
On 11/05/2026
Canadian researchers used two tools designed to assess bulbar function in adults with SMN1-related proximal spinal muscular atrophy (SMA): 15 adults with SMA took part…
Signing of a partnership with the University Hospital and the University of Orléans to enhance research, clinical care and teaching in the field of myology
On 07/05/2026
Laurence Tiennot-Herment, President of the Myology Institute Association, Sébastien Vial, Director General of Orléans University Hospital, and Sébastien Ringuedé, Vice-President in charge of the Training…
Ten years of diagnosing congenital muscular dystrophies and congenital myopathies in the UK
On 04/05/2026
The team at Great Ormond Street Hospital in London compiled clinical and molecular data from patients suspected of having congenital myopathy or congenital muscular dystrophy…
ERN EURO-NMD webinar, 7 May : Prof. Mathilde Duchesne (France)
On 30/04/2026
Episode 4 – Infectious and Neoplastic Neuropathies (in EURO-NMD Neuropathology Webinar Series) Thursday 7 May 2026 – 16:00-17:00 Paris time Speaker: Prof. Mathilde Duchesne (CHU Limoges,…
Late-onset facio-scapulo-humeral muscular dystrophy constitutes a distinct group
On 30/04/2026
An international consortium of experts on facioscapulohumeral muscular dystrophy (FSHD) has compiled observations from patients diagnosed at a relatively advanced age: using clinical and biological…
Gaining a better understanding of the cause of two deaths linked to dilandistrogene moxeparvovec in order to better prevent them
On 29/04/2026
US experts in gene therapy for Duchenne muscular dystrophy (DMD) have investigated the causes of two deaths that occurred in 2025 and were attributed to…
Rapamycin: an adjunctive treatment for post-gene therapy hepatotoxicity with AAV?
On 28/04/2026
American specialists in gene therapy using adeno-associated viruses (AAV) have investigated the serious cases of liver toxicity that occurred during gene therapy with microdystrophin (delandistrogene…
The programme for the 2026 Muscle Conference is now available online
On 27/04/2026
Muscles lie at the heart of all the major challenges facing our modern societies: the prevention of common, serious and disabling conditions; the fight against…
Study on a very rare form of core myopathy
On 27/04/2026
A study conducted in the Île-de-France region, involving researchers and clinicians from the Institute, describes the case of a patient who was diagnosed with congenital…
The effect of nusinersen on taurine metabolism in SMA
On 24/04/2026
Italian researchers have been investigating taurine, a naturally occurring amino acid whose metabolism appears to be affected in proximal spinal muscular atrophy (SMA): they first…
2nd Muscle Conference: ‘Muscle throughout life’ – Tuesday 2 June
On 22/04/2026
Muscle is now recognized as an essential organ for health at every stage of life, from before birth and into old age. It lies at the heart of major challenges facing modern societies: preventing common, serious…
Is there an increased risk of cancer in autoimmune myasthenia gravis?
On 22/04/2026
Israeli researchers have investigated the risk of developing cancers other than thymoma in patients with autoimmune myasthenia gravis: data on 1,558 adults with myasthenia gravis…
An in-depth and informative analysis of two false-positive cases in neonatal screening for SMA
On 21/04/2026
German and Australian researchers report the case of two newborns who tested positive at birth for SMA: during the initial routine analysis, a homozygous deletion…
A questionnaire to assess the impact of non-dystrophic myotonias
On 21/04/2026
A French consortium of experts, coordinated by the Nice Neuromuscular Reference Centre, has developed a questionnaire called Active-NMD: this new tool is designed for patients…
Ticket sales opened for the ‘Match of Heroes’ on May 31
On 20/04/2026
Paul de Saint-Sernin, Eden Hazard, Paul Mirabel, Dominique Rocheteau, Javier Pastore, Robert Pirès, Artus, Stéphane Ruffier… all coming together for an exceptional “Match of Heroes”…
Rare forms of transition between dermatomyositis and ankylosing spondylitis
On 20/04/2026
American clinicians investigated a number of cases of juvenile dermatomyositis (JDM) in which symptoms and signs consistent with one of the three forms (axial, peripheral…